Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 2021

View Archived Issues

Human cerebral organoids show utility to evaluate candidate inhibitors of prion accumulation in CJD

Phase III GOBI study of NOV-03 meets statistical significance on coprimary and secondary endpoints

BMC-128 shows promising antitumor activity in mouse model of melanoma

Phase II study of fostamatinib in patients with COVID-19 meets primary endpoint

FDA clears IND application for phase IIb study of AXA-1125 in NASH

Companies report progress of catumaxomab clinical trials for NMIBC

CFT-7455 shows potent tumor regression in IMiD-resistant multiple myeloma xenografts

First-in-class pan-inhibitor of KDM4 TACH-101 active in multiple cancer models

SPH Biotherapeutics presents new isolated antigen-binding proteins

New PARG inhibitors identified at Ideaya Biosciences

Accutar Biotechnology synthesizes new androgen receptor degrading PROTACs

Merck & Co. presents a novel potent, selective and brain-penetrant LRRK2 kinase inhibitor

Merck & Co. discovers KRAS G12C mutant inhibitors

BIAL Biotech discovers acid ceramidase inhibitors

BNT-162b2 and mRNA-1273 achieve only partial cross-neutralization of novel SARS-CoV-2 variants

Longeveron reports final phase I data on Lomecel-B in Alzheimer's disease

Development of human African trypanosomiasis carbazole drugs

New agonist MAb resolves chronic inflammation

New phase II trials evaluate BI-456906 in obesity and NASH

Tilt and MSD agree to study TILT-123 with Keytruda in ovarian cancer

Bispecific antibody targeting LAG-3 and PD-L1 (ABL501) for cancer immunotherapy

Iterion completes enrollment in phase I/IIa dose-expansion study of tegavivint in desmoid tumors

Moderna updates progress of COVID-19 vaccine program

Apellis reports 24-month data from phase Ib study of pegcetacoplan in geographic atrophy

Trodelvy gains accelerated approval in U.S. for advanced urothelial cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...